Actis eyes Indian life science labs demand with Rx Propellant deal
Global sustainable infrastructure investor Actis has bought Rx Propellant, a platform focused on providing R&D labs and facilities to tenants in the life sciences and related sectors in India. The post Actis eyes Indian life
